Role of systolic blood pressure and plasma triglycerides in diabetic peripheral-arterial disease: The Edinburgh Artery Study

Diabetes Care

Volumn 22, Issue 3, 1999, Pages 453-458

  Macgregor, Andrew S ^a   Price, Jacqueline F ^a   Hau, Cathryn M ^a   Lee, Amanda J ^a   Carson, Maggie N ^a   Fowkes, F Gerald R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032971915     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.3.453     Document Type: Article

References (36)

1. Kannel WB, McGee DL: Diabetes and cardiovascular disease. JAMA 241:2035-2038, 1979
2. Garcia M, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23:105-111, 1974
3. Bell DSH: Review in depth: diabetes mellitus and coronary artery disease. J Cardiovasc Risk 4:83-90, 1997
4. Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol 34:29-34, 1974
5. Kannel WB, D'Agostino RB, Wilson PWF, Belanger AJ, Gagnon DR: Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 120: 3672-3676, 1990
6. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. Br Med J 287:867-870, 1983
7. Uusitupa M, Siitonen O, Aro A, Pyorala K: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged newly diagnosed type 2 (non-insulin dependent) diabetic subjects. Diabetologia 28:22-27, 1985
8. Jarrett RJ: Diabetes mellitus. In Epidemiology of Peripheral Vascular Disease. Fowkes FGR, Ed. Berlin, Springer-Verlag, 1991, p. 187-193
9. Murabito JM, D'Agostino RB, Silbershatz H, Wilson PWF: Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 96:44-49, 1997
10. Feskens EJM, Kromhout D: Glucose tolerance and the risk of cardiovascular diseases: the Zutphen Study. J Clin Epidemiol 45:1327-1334, 1992
11. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutillainen E, Pyorala K: 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin dependent diabetic and non-diabetic subjects. Circulation 82:27-36, 1990
12. Nelson RG, Gohdes DM, Everhart J, Hartner JA, Zwemmer FL, Pettitt DJ, Knowler WC: Lower extremity amputations in NIDDM: 12-year follow-up in Pima Indians. Diabetes Care 11:8-16, 1988
13. Everhart JE, Pettitt DJ, Knowler WC, Rose FA, Bennett PH: Medial arterial calcification and its association with mortality and complications of diabetes. Diabetalogia 31:16-23, 1988
14. Herman JB, Medalie JH, Goldbourt U: Differences in cardiovascular morbidity and mortality between previously known and newly-diagnosed adult diabetics. Diabetologia 13:229-234, 1977
15. Nilsson SV, Nilsson JE, Frostber N, Emilsson T: The Kristianstad survey. II. Studies in a representative adult diabetic population with special reference to comparison with an adequate control group. Acta Med Scand Suppl 469:1-42, 1967
16. Mehler PS, Jeffers WJ, Estacio R, Schrier RW: Associations of hypertension and complications in non-insulin-dependent diabetes mellitus. Am J Hyper 10:152-161, 1997
17. Al Zahrani AH, Al Bar HMS, Bahnassi A, Abdulaal AA: The distribution of peripheral arterial disease in a defined population of elderly high-risk Saudi patients. Int Angiol 16:123-128, 1997
18. Janka HU, Standl E, Mehnert H: Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the doppler ultrasound technique. Diabetes Care 3:207-213, 1980
19. Paisey RB, Arredondo G, Villalobos A, Lozano O, Guevara L, Kelly S: Association of differing dietary, metabolic and clinical risk factors with macrovascular complications of diabetes a prevalence study of 503 Mexican type II diabetic subjects. Diabetes Care 7:421-427, 1984
20. Breddin HK, Krzywanek HJ, Althoff P, Kirchmaier CM, Rosak C, Schepping M, Weichert W, Ziemen M, Schoffling K, Uberla K: Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics: results of the PARD study. Int Angiol 5:181-195, 1986
21. Kreines K, Johnson E, Albrink M, Knatterud GL, Levin ME, Lewitan A, Newberry W, Rose FA: The course of peripheral vascular disease in non-insulin-dependent diabetes. Diabetes Care 8:235-243, 1985
22. Walters DP, Gatling W, Mullee MA, Hill RD: The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet Med 9:710-715, 1992
23. Maser RE, Wolfson SK, Ellis D, Stein EA, Drash AL, Becker DJ, Dorman JS, Orchard TJ: Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Arterioscler Thromb 11:958-965, 1991
24. Fowkes FGR, Housley E, Cawood EHH, MacIntyre CCA, Ruckley CV, Prescott RJ: Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20:384-392, 1991
25. Rose GA: The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 27:645-658, 1962
26. Fowkes FGR: The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 17: 248-254, 1988
27. Johnson WC. Doppler ankle pressure and reactive hyperaemia in the diagnosis of arterial insufficiency. J Surg Res 18:177-180, 1975
28. Friedwald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
29. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 727)
30. SAS/STAT Software: The GENMOD procedure, release 6.09. Cary, NC, SAS Institute, 1993 (SAS Technical Report P-243)
31. Mackaay AJC, Beks PJ, Dur AHM, Bischoff M, Scholma J, Heine RJ, Rauwerda JA: The distribution of peripheral vascular disease in a Dutch Caucasian population: comparison of type II diabetic and non-diabetic subjects. Eur J Vasc Endovasc Surg 9:170-175, 1995
32. Mohan V, Vijayaprabha R, Rema M: Vascular complications in long-term South Indian NIDDM of over 25 years' duration. Diab Res Clin Pract 31:133-140, 1996
33. West KM, Ahuja MMS, Bennett PH, Czyzyk A, De Acosta OM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K, Keen H, Krolewski AS, Miki E, Schliack V, Teuscher A, Watkins PJ, Stober JA: The role of circulating glucose and triglyceride concentrations and their interactions with other risk factors as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care 6:4:361-369, 1983
34. Leng GC, Evans CJ, Fowkes FGR: Epidemiology of peripheral vascular diseases. Imaging 7:85-96, 1995
35. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
36. Price JF, Lee AJ, Fowkes FGR: Hyperinsulinaemia: a risk factor for peripheral arterial disease in the non-diabetic general population. J Cardiovasc Risk 3:501-505, 1997